![Ken E. Drazan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ken E. Drazan
Vorstandsvorsitzender bei
Arsenal Biosciences, Inc.
Profil
Ken E.
Drazan is the founder of ArgiNOx Pharmaceuticals, Inc., Arsenal Biosciences, Inc. Dr. Drazan is currently a Surgeon at Stanford University.
Formerly, Dr. Drazan was Executive Chairman at GENASCIS LLC, Basic Scientist at the University of California, Los Angeles, General Partner at Bertram Capital Management LLC from 2010 to 2011, and President at GRAIL, Inc. Dr. Drazan completed undergraduate studies at Yale University and earned a doctorate from The State University of New York.
Aktive Positionen von Ken E. Drazan
| Unternehmen | Position | Beginn |
|---|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Ken E. Drazan
| Unternehmen | Position | Ende |
|---|---|---|
| GRAIL, INC. | Präsident | 01.08.2018 |
GENASCIS LLC
 GENASCIS LLC Packaged SoftwareTechnology Services Provides revenue cycle management services for ambulatory surgery centers | Vorsitzender | - |
Bertram Capital Management LLC
 Bertram Capital Management LLC Investment ManagersFinance Bertram Capital Mgmt invests in middle-market companies located in the United States with an enterprise value of USD 50 - 500 million, an EBITDA of USD 5 - 35 million and revenues of USD 20 - 250 million. The firm focuses on sectors such as business services, consumer, industrial/manufacturing and technology. It participates in divestitures, MBO, shareholder liquidity events with an investment size of USD 25 - 250 million. The firm acquires controlling interests. | Private Equity Investor | - |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
ArgiNOx Pharmaceuticals, Inc.
 ArgiNOx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Gründer | - |
Ausbildung von Ken E. Drazan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
98
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
ArgiNOx Pharmaceuticals, Inc.
ArgiNOx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bertram Capital Management LLC
Bertram Capital Management LLC Investment ManagersFinance Bertram Capital Mgmt invests in middle-market companies located in the United States with an enterprise value of USD 50 - 500 million, an EBITDA of USD 5 - 35 million and revenues of USD 20 - 250 million. The firm focuses on sectors such as business services, consumer, industrial/manufacturing and technology. It participates in divestitures, MBO, shareholder liquidity events with an investment size of USD 25 - 250 million. The firm acquires controlling interests. | Finance |
GENASCIS LLC
GENASCIS LLC Packaged SoftwareTechnology Services Provides revenue cycle management services for ambulatory surgery centers | Technology Services |
GRAIL, Inc.
 GRAIL, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection test kits and provides related services | Health Technology |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Technology Services |
